title: [Management of capecitabine-induced hand-foot syndrome by local phytotherapy].
abstract: The so-called hand-foot syndrome (HFS) is a dose-limiting side effect with only rare therapeutic options in cancer patients treated with capecitabine (Xeloda). Depending on the intensity of the skin reaction dose reduction, interruption or even the break-off of capecitabine therapy is necessary. We therefore try to describe a new and promising alternative treatment of the hand-foot syndrome, a local therapy with a mixture of herbal medicinal products mainly consisting of hand- and foot baths, and present the promising results of this treatment modality observed in 11 consecutive patients.
authors: Anstaltsapotheke des Krankenhauses der Barmherzigen Schwestern, Linz, Austria.
authors: Elisabeth
authors: E
authors: Kern
authors: Manuela
authors: M
authors: Schmidinger
authors: Gottfried J
authors: GJ
authors: Locker
authors: Brigitte
authors: B
authors: Kopp
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D020838:Calendula; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005533:Foot Dermatoses / Q000139:chemically induced* / Q000188:drug therapy*; D006229:Hand Dermatoses / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D031168:Matricaria; D008517:Phytotherapy; D027544:Salvia; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil
references: Oncology (Williston Park). 2004 Aug;18(9):1161-8, 1173; discussion 1173-6, 1181-4
references: 15471200
references: J Oncol Pharm Pract. 2006 Sep;12(3):131-41
references: 17022868
references: Clin Cancer Res. 1998 Jun;4(6):1567-71
references: 9626479
references: Breast. 2006 Jun;15(3):414-24
references: 16188440
references: Eur J Oncol Nurs. 2004;8 Suppl 1:S16-30
references: 15341879
references: J Ethnopharmacol. 1997 Jul;57(2):139-44
references: 9254116
references: Cancer Chemother Pharmacol. 1999;44(4):303-6
references: 10447577
references: J Ethnopharmacol. 2001 May;75(2-3):125-32
references: 11297842
references: J Am Acad Dermatol. 1991 Jun;24(6 Pt 1):1023-5
references: 1869670
references: Oncology (Williston Park). 2002 Dec;16(12 Suppl No 14):31-7
references: 12520638
references: Schweiz Med Wochenschr. 2000 Oct 7;130(40):1413-6
references: 11059033